Performance
Can You Have High Testosterone and Still Feel Tired? Absolutely.
Testosterone can influence how you feel and perform. But it isn’t a battery meter — and fatigue has far more than one cause.
By The ROWR editorial teamLast updated 27 August 2026
Quick answer
Yes. Men with normal or high testosterone can still experience persistent fatigue. Testosterone influences muscle, bone, libido, mood and body composition, but daytime energy is also governed by sleep quality, energy intake, training load, stress and medical factors such as thyroid function, iron status and sleep apnoea. In the NIH-funded Testosterone Trials, raising testosterone in older men with low levels did not produce a significant improvement in the trial’s primary vitality outcome.
Testosterone isn’t a battery meter
The popular mental model is that testosterone is a fuel gauge: high means energetic, low means flat. It is a tidy model and it is wrong.
Testosterone is a signalling hormone with specific jobs — maintaining muscle and bone, supporting libido and sexual function, influencing red blood cell production, body composition and aspects of mood. Daytime energy is a downstream outcome of many systems: how much you slept and how well, whether you ate enough, how much unrecovered training you are carrying, how long your stress has been running, and whether something medical is going on.
Healthy testosterone and high daytime energy overlap. They are not the same physiological job.
Why fatigue gets mistaken for low testosterone
The symptom list attributed to low testosterone — tiredness, low mood, poor concentration, reduced drive, worse gym performance — is almost entirely non-specific. Every item on it appears on the symptom lists of a dozen other things.
Insufficient sleep produces it. Untreated sleep apnoea produces it. Iron deficiency, thyroid dysfunction, depression, chronic under-eating, alcohol, some medications and simple long-term overreaching all produce it.
That overlap is why “I’m tired, it must be my T” is such an easy conclusion, and why it is so often incomplete. It is also why a fatigue investigation that stops at one testosterone test can miss the actual answer.
What happened when researchers actually raised testosterone?
The Testosterone Trials were a coordinated set of NIH-funded placebo-controlled trials in men aged 65 and over with unequivocally low testosterone. Participants received testosterone gel or placebo for one year, and serum testosterone in the treated group rose to the range typical of younger men.
The sexual function trial met its endpoint. The vitality trial did not: the proportion of men reporting a meaningful improvement in vitality was not significantly greater with testosterone than with placebo, although smaller improvements in mood and depressive symptoms were observed.
That result deserves careful reading. It does not mean testosterone is unrelated to how you feel — in men with genuine deficiency, treatment can matter a great deal. It means that in this population, moving the number upward did not reliably remove the fatigue. Whatever was making those men tired was not solved by testosterone alone.
Energy deserves its own strategy
If fatigue has multiple inputs, it needs to be addressed on multiple fronts rather than delegated to one hormone.
In practice, the highest-yield inputs are unglamorous: consistent sleep duration and timing, enough total energy and protein to cover your training, a training load that includes planned easy days, some management of chronic stress, and a clinical check when fatigue is severe, persistent or new.
Fatigue resistance — holding output and attention through a long day — is its own trainable quality, and it responds to those inputs far more than to any single biomarker.
- Sleep: duration and regularity before optimisation tricks.
- Fuel: chronic underfuelling reliably produces fatigue.
- Load: hard days are only useful if easy days exist.
- Stress: unrelenting stress load is a physiological cost, not a character flaw.
- Clinical: persistent or severe fatigue warrants proper medical assessment.
Why ROWR separates testosterone support from daytime performance
This distinction is a formulation decision, not a marketing angle. If testosterone support and daytime energy are different jobs, one ingredient should not be asked to do both.
PRIME / AM uses Tongkat Ali and Shilajit for testosterone-related support at doses aligned with human research. It does not ask those ingredients to also deliver daytime fatigue resistance.
That job is given to a separate ingredient, chosen for a separate body of evidence.
Rhodiola has its own job
PRIME / AM contains 200 mg of Rhodiola rosea root and rhizome extract, standardised to 3% rosavins and 1% salidroside.
Its role in the formula is daytime energy, fatigue resistance and endurance. The dose and standardisation align with controlled human research examining endurance performance and fatigue-related outcomes, including a randomised trial using 200 mg of standardised Rhodiola before exercise, and trials in physicians on night duty and in adults with stress-related fatigue.
Rhodiola is not in PRIME to raise testosterone, and we do not claim it does. It is there because the afternoon is a different problem from the hormone.
Key studies
Effects of Testosterone Treatment in Older Men (The Testosterone Trials)
New England Journal of Medicine, 2016
- Population
- 790 men aged 65+ with low testosterone
- Dose
- Testosterone gel vs placebo
- Duration
- 12 months
Testosterone treatment raised serum testosterone to the mid-normal range for young men and improved sexual function, but did not significantly improve the trial’s primary vitality outcome versus placebo.
Acute Rhodiola rosea intake can improve endurance exercise performance
International Journal of Sport Nutrition and Exercise Metabolism, 2004
- Population
- 24 healthy young adults, randomised crossover
- Dose
- 200 mg standardised Rhodiola rosea (3% rosavins, 1% salidroside)
- Duration
- Acute, pre-exercise
Improved time to exhaustion and VO₂ peak during a cycling endurance test compared with placebo.
A randomised trial of two different doses of a SHR-5 Rhodiola rosea extract in burnout patients with fatigue syndrome
Planta Medica, 2009
- Population
- 60 adults with stress-related fatigue
- Dose
- SHR-5 Rhodiola rosea extract
- Duration
- 28 days
Reduced fatigue symptoms and improved attention versus placebo, with an accompanying reduction in the cortisol awakening response.
A randomised, double-blind, placebo-controlled study of the standardised extract SHR-5 on fatigue during night duty
Phytomedicine, 2000
- Population
- 56 healthy physicians on night duty
- Dose
- 170 mg standardised Rhodiola rosea extract daily
- Duration
- 2 weeks
Reduced a composite index of fatigue affecting mental performance during night shifts compared with placebo.